Patents by Inventor Elizabeth Joseloff

Elizabeth Joseloff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210277073
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with kidney. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in kidney diseases (KCAT) and antibodies binds to KCATs. The present invention provides that KCATs are used as targets for screening agents that modulates the KCAT activities. Further the present invention provides methods for treating diseases associated with kidney.
    Type: Application
    Filed: January 7, 2021
    Publication date: September 9, 2021
    Inventors: Elizabeth JOSELOFF, Steve RUBEN, Tao HE
  • Publication number: 20200276329
    Abstract: Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.
    Type: Application
    Filed: January 8, 2020
    Publication date: September 3, 2020
    Inventors: Steve RUBEN, Karen VAN ORDEN, Bruno DOMON, Candy LEE, Tao HE, Mehdi MESRI, Elizabeth JOSELOFF, Katherine MCKINNON, Paul MOORE, Charles BIRSE
  • Publication number: 20190233484
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with kidney. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in kidney diseases (KCAT) and antibodies binds to KCATs. The present invention provides that KCATs are used as targets for screening agents that modulates the KCAT activities. Further the present invention provides methods for treating diseases associated with kidney.
    Type: Application
    Filed: December 5, 2018
    Publication date: August 1, 2019
    Inventors: Elizabeth Joseloff, Steve Ruben, Tao He
  • Publication number: 20170350897
    Abstract: Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.
    Type: Application
    Filed: April 12, 2017
    Publication date: December 7, 2017
    Inventors: Steve RUBEN, Karen VAN ORDEN, Bruno DOMON, Candy LEE, Tao HE, Mehdi MESRI, Elizabeth JOSELOFF, Katherine MCKINNON, Paul MOORE, Charles BIRSE
  • Publication number: 20160362461
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with kidney. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in kidney diseases (KCAT) and antibodies binds to KCATs. The present invention provides that KCATs are used as targets for screening agents that modulates the KCAT activities. Further the present invention provides methods for treating diseases associated with kidney.
    Type: Application
    Filed: April 19, 2016
    Publication date: December 15, 2016
    Inventors: Elizabeth JOSELOFF, Steve RUBEN, Tao HE
  • Publication number: 20160161494
    Abstract: Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.
    Type: Application
    Filed: June 19, 2015
    Publication date: June 9, 2016
    Inventors: Steve RUBEN, Karen VAN ORDEN, Bruno DOMON, Candy LEE, Tao HE, Mehdi MESRI, Elizabeth JOSELOFF, Katherine MCKINNON, Paul MOORE, Charles BIRSE
  • Publication number: 20140314768
    Abstract: Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.
    Type: Application
    Filed: December 6, 2013
    Publication date: October 23, 2014
    Applicant: CELERA CORPORATION
    Inventors: Steve RUBEN, Karen VAN ORDEN, Bruno DOMON, Candy LEE, Tao HE, Mehdi MESRI, Elizabeth JOSELOFF, Katherine MCKINNON, Paul MOORE, Charles BIRSE
  • Publication number: 20140314770
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with kidney. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in kidney diseases (KCAT) and antibodies binds to KCATs. The present invention provides that KCATs are used as targets for screening agents that modulates the KCAT activities. Further the present invention provides methods for treating diseases associated with kidney.
    Type: Application
    Filed: February 5, 2014
    Publication date: October 23, 2014
    Applicant: Celera Corporation
    Inventors: Elizabeth JOSELOFF, Steve RUBEN, Tao HE
  • Publication number: 20140193419
    Abstract: Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.
    Type: Application
    Filed: December 6, 2013
    Publication date: July 10, 2014
    Applicant: CELERA CORPORATION
    Inventors: Steve RUBEN, Karen VAN ORDEN, Bruno DOMON, Candy LEE, Tao HE, Mehdi MESRI, Elizabeth JOSELOFF, Katherine MCKINNON, Paul MOORE, Charles BIRSE
  • Publication number: 20120183552
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with kidney. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in kidney diseases (KCAT) and antibodies binds to KCATs. The present invention provides that KCATs are used as targets for screening agents that modulates the KCAT activities. Further the present invention provides methods for treating diseases associated with kidney.
    Type: Application
    Filed: July 15, 2011
    Publication date: July 19, 2012
    Applicant: CELERA CORPORATION
    Inventors: Elizabeth JOSELOFF, Steve RUBEN, Tao HE, Yeounjin KIM
  • Publication number: 20110219464
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in lung cancer (LCAT) and antibodies binds to LCATs. The present invention provides that LCATs are used as targets for screening agents that modulates the LCAT activities. Further the present invention provides methods for treating diseases associated with lung.
    Type: Application
    Filed: August 25, 2010
    Publication date: September 8, 2011
    Applicant: CELERA CORPORATION
    Inventors: Bruno DOMON, Elizabeth JOSELOFF, Aiqun LI, Tao HE
  • Publication number: 20110212085
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in lung diseases (LCAT) and antibodies binds to LCATs. The present invention provides that LCATs are used as targets for screening agents that modulates the LCAT activities. Further the present invention provides methods for treating diseases associated with lung.
    Type: Application
    Filed: August 19, 2010
    Publication date: September 1, 2011
    Applicant: CELERA CORPORATION
    Inventors: Elizabeth JOSELOFF, Aiqun LI, Tao HE, Steve RUBEN
  • Patent number: 7998689
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with kidney. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in kidney diseases (KCAT) and antibodies binds to KCATs. The present invention provides that KCATs are used as targets for screening agents that modulates the KCAT activities. Further the present invention provides methods for treating diseases associated with kidney.
    Type: Grant
    Filed: September 10, 2009
    Date of Patent: August 16, 2011
    Assignee: Celera Corporation
    Inventors: Elizabeth Joseloff, Steve Ruben, Tao He, Yeounjin Kim
  • Patent number: 7807392
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in lung cancer (LCAT) and antibodies binds to LCATs. The present invention provides that LCATs are used as targets for screening agents that modulates the LCAT activities. Further the present invention provides methods for treating diseases associated with lung.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: October 5, 2010
    Assignee: Celera Corporation
    Inventors: Bruno Domon, Elizabeth Joseloff, Aiqun Li, Tao He
  • Publication number: 20100239581
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with kidney. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in kidney diseases (KCAT) and antibodies binds to KCATs. The present invention provides that KCATs are used as targets for screening agents that modulates the KCAT activities. Further the present invention provides methods for treating diseases associated with kidney.
    Type: Application
    Filed: September 10, 2009
    Publication date: September 23, 2010
    Applicant: CELERA CORPORATION
    Inventors: Elizabeth JOSELOFF, Steve RUBEN, Tao HE, Yeounjin KIM
  • Patent number: 7608413
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with kidney. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in kidney diseases (KCAT) and antibodies binds to KCATs. The present invention provides that KCATs are used as targets for screening agents that modulates the KCAT activities. Further the present invention provides methods for treating diseases associated with kidney.
    Type: Grant
    Filed: July 20, 2007
    Date of Patent: October 27, 2009
    Assignee: Celera Corporation
    Inventors: Elizabeth Joseloff, Steve Ruben, Tao He, Yeoun Jim Kim
  • Publication number: 20090232822
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in lung diseases (LCAT) and antibodies binds to LCATs. The present invention provides that LCATs are used as targets for screening agents that modulates the LCAT activities. Further the present invention provides methods for treating diseases associated with lung.
    Type: Application
    Filed: March 9, 2009
    Publication date: September 17, 2009
    Applicant: CELERA CORPORATION
    Inventors: Elizabeth JOSELOFF, Aiqun LI, Tao HE, Steven RUBEN
  • Patent number: 7521195
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in lung diseases (LCAT) and antibodies binds to LCATs. The present invention provides that LCATs are used as targets for screening agents that modulates the LCAT activities. Further the present invention provides methods for treating diseases associated with lung.
    Type: Grant
    Filed: July 21, 2006
    Date of Patent: April 21, 2009
    Assignee: Celera Corporation
    Inventors: Elizabeth Joseloff, Aiqun Li, Tao He, Steve Ruben